Eaton-Fitch, Natalie, Cabanas, Hélène, du Preez, Stanley et al. · Journal of translational medicine · 2021 · DOI
This study looked at immune cells called NK cells in ME/CFS patients and compared them to healthy people. The researchers focused on a protein channel called TRPM3 that helps control calcium levels in cells, which may be important for immune function. They found that this channel doesn't work properly in ME/CFS patients, but when cells were stimulated with a chemical called IL-2, the NK cells from ME/CFS patients could kill viruses and abnormal cells as effectively as healthy people's cells.
Identifying impaired TRPM3 function and calcium signaling in ME/CFS patients provides a potential mechanistic explanation for the well-documented NK cell dysfunction in this disease. The finding that IL-2 stimulation can restore NK cytotoxicity suggests a possible therapeutic avenue, while the pinpointing of TRPM3-PIP₂ dysregulation offers a specific molecular target for future drug development.
This study does not prove that TRPM3 dysfunction causes ME/CFS or that treating TRPM3 will cure the disease—it only shows an association between impaired TRPM3 function and reduced NK cell activity in this disease. The study used cells in laboratory conditions (in vitro), so results may not directly translate to what happens in patients' bodies. The small sample size (15 per group) means findings require replication before drawing firm conclusions.
About the PEM badge: “PEM required” means post-exertional malaise was an explicit required diagnostic criterion for participant inclusion in this study — not that PEM was studied, observed, or discussed. Studies using criteria that do not require PEM (e.g. Fukuda, Oxford) are tagged “PEM not required”. How the atlas works →
The first block is for the primary paper and is the citation you should use in research work. The atlas-snapshot line only applies if you are specifically referring to this atlas’s reading of the paper on the date shown.
Primary citation
Eaton-Fitch, Natalie, Cabanas, Hélène, du Preez, Stanley, Staines, Donald, & Marshall-Gradisnik, Sonya (2021). The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP<sub>2</sub> and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.. Journal of translational medicine. https://doi.org/10.1186/s12967-021-02974-4
BibTeX
@article{mecfsatlas-eaton-fitch-2021-effect-stimulation,
author = {Eaton-Fitch, Natalie and Cabanas, Hélène and du Preez, Stanley and Staines, Donald and Marshall-Gradisnik, Sonya},
title = {The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP<sub>2</sub> and NK cell function in myalgic encephalomyelitis/chronic fatigue syndrome patients.},
journal = {Journal of translational medicine},
year = {2021},
doi = {10.1186/s12967-021-02974-4},
note = {PubMed: 34266470},
url = {https://www.mecfsatlas.com/evidence/eaton-fitch-2021-effect-stimulation},
}Atlas snapshot reference
ME/CFS Atlas. Generator v1 / Scanner v1.4 / policy v0.1. Accessed 2026-05-27. https://www.mecfsatlas.com/evidence/eaton-fitch-2021-effect-stimulation
Contribute
Private, reviewed by a human. Not a public comment thread.